These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29844042)

  • 21. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii.
    Tiwari M; Roy R; Tiwari V
    Microb Drug Resist; 2016 Jul; 22(5):364-71. PubMed ID: 26910023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Origanum vulgare L. essential oil inhibits the growth of carbapenem-resistant gram-negative bacteria.
    Vasconcelos NG; Croda J; Silva KE; Motta MLL; Maciel WG; Limiere LC; Simionatto S
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20180502. PubMed ID: 31271619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W; Wang R; Chai D; Li Z; Pei F
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    Brennan-Krohn T; Truelson KA; Smith KP; Kirby JE
    J Antimicrob Chemother; 2017 Oct; 72(10):2775-2781. PubMed ID: 29091221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
    Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
    New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
    Oliva A; Garzoli S; De Angelis M; Marzuillo C; Vullo V; Mastroianni CM; Ragno R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Alharbe R; Almansour A; Kwon DH
    Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
    Thamlikitkul V; Tiengrim S; Seenama C
    Int J Antimicrob Agents; 2016 Jan; 47(1):101-2. PubMed ID: 26725031
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
    Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
    J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
    Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Lenhard JR; Gall JS; Bulitta JB; Thamlikitkul V; Landersdorfer CB; Forrest A; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2016 Dec; 48(6):719-724. PubMed ID: 27773498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.